FDA
approval
· 2015-04-28
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)
Summary
The FDA approved a supplemental application for the generic fixed-dose combination of irbesartan and hydrochlorothiazide manufactured by Solco Healthcare US, LL…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)